USP 797 Revisions: How it Started, How it’s going

Join our panel of compounding experts as they share their experiences on preparedness, successes, lessons learned, and operational pivots during their journey to compounding compliance.

WEBINAR: 12pm ET/9am PT

USP <797> Revision: How it Started, How it’s going

About

USP <797> Revision: How it Started, How it’s going 


Craig Greszler will moderate a panel of three distinguished panelists discussing the United States Pharmacopeia (USP) latest draft revisions to chapter <797> on 11/1/2023. Since the official release, health systems are now held accountable for the updated standards outlined within the chapter. While the ultimate goal of patient safety remains, several changes, which include beyond-use dating, required training, and increased environmental monitoring, present potential barriers to adoption. Join this panel of compounding experts as they share their experiences on preparedness, successes, lessons learned, and operational pivots during their journey to compounding compliance.

Stay tuned to this page as we continue our webinar series focused on the USP revisions.

June 2024: USP <795>

September 2024: USP <800>

Speakers
Michael Freudiger, PharmD, APh, BCPS, BCSCP
Panelist
Joshua Smallwood, PharmD
Panelist
Kristine Smith, BS, CPhT-Adv, CSPT
Panelist
Craig Greszler, PharmD, MBA, BCSCP
Moderator
Related Product

Registration

Tuesday, March 5 at 12pm ET/9am PT

USP <797> Revision: How it’s going

Helpful Information
  • Define metrics for successful adoption of USP <797> revisions.
  •  Identify methods used to prepare for upcoming audits of USP <797> compliance.
  • Outline post-adoption obstacles and summarize strategies to overcome these challenges.
  • Determine when to iterate on adoption strategies.
Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×